SMTL ID : 3bkl.1

Testis ACE co-crystal structure with ketone ACE inhibitor kAW

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.18 Å

Oligo State

monomer

Ligands

1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-FUC.1: 6 residues within 4Å: Chain A: S.9, V.12, E.13, N.73, T.75, I.76 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:V.12, A:E.13, A:I.76, A:T.75 Hydrogen bonds: A:E.13

2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)

NAG.2: 6 residues within 4Å: Chain A: N.36, T.38, E.40, T.41, D.310, R.312 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.36, A:E.40 NAG.3: 6 residues within 4Å: Chain A: D.16, Q.20, D.360, L.361, P.362, R.366 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:Q.20, A:Q.20, A:D.360, A:D.360, A:R.366

1 x ZN: ZINC ION(Non-covalent)

ZN.4: 4 residues within 4Å: Chain A: H.347, H.351, E.375 Ligands: KAW.10 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.347, A:H.351, A:E.375

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.5: 5 residues within 4Å: Chain A: R.150, W.449, W.450, R.453, D.471 Ligand excluded by PLIP CL.6: 6 residues within 4Å: Chain A: M.187, Y.188, P.371, P.483, I.485, R.486 Ligand excluded by PLIP

3 x ACT: ACETATE ION(Non-functional Binders)

ACT.7: 9 residues within 4Å: Chain A: L.158, K.442, E.443, N.444, Y.445, N.446, Q.447, G.468, D.469 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.446, A:D.469 ACT.8: 4 residues within 4Å: Chain A: N.30, A.320, W.321 Ligands: KAW.10 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.30, A:A.320 ACT.9: 4 residues within 4Å: Chain A: G.28, W.31, N.32, R.330 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.32 Salt bridges: A:R.330

1 x KAW: N-{(5S)-4,4-dihydroxy-6-phenyl-5-[(phenylcarbonyl)amino]hexanoyl}-L-tryptophan(Non-covalent)

KAW.10: 22 residues within 4Å: Chain A: Q.245, H.317, A.318, S.319, A.320, H.347, E.348, H.351, F.355, H.374, E.375, D.379, F.421, K.475, F.476, H.477, V.482, Y.484, Y.487 Ligands: ZN.4, ACT.8, GOL.11 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:F.355, A:F.421, A:F.476, A:F.476, A:V.482, A:V.482, A:Y.487 Hydrogen bonds: A:Q.245, A:A.320, A:Y.487 Water bridges: A:H.347, A:E.375, A:Y.487 Salt bridges: A:H.317, A:K.475, A:H.477 pi-Stacking: A:H.351, A:F.491

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.11: 6 residues within 4Å: Chain A: N.241, W.243, Q.245, T.246, E.340 Ligands: KAW.10 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:N.241, A:Q.245 Water bridges: A:Q.245, A:T.246, A:D.417

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Watermeyer, J.M. et al., Probing the basis of domain-dependent inhibition using novel ketone inhibitors of Angiotensin-converting enzyme. Biochemistry (2008)

Release Date

2008-06-10

Peptides

Angiotensin-converting enzyme, somatic isoform: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Angiotensin-converting enzyme, somatic isoform

Related Entries With Identical Sequence